Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 2/2013

01.06.2013 | short review

New developments in acute graft-versus-host disease

verfasst von: Hildegard T. Greinix, Margit Mitterbauer, MD, Werner Rabitsch, MD, Nina Worel, MD, Ulrike Just, MD, Robert Knobler, MD, Peter Kalhs, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is a well-established curative treatment option for selected patients with hematologic and oncologic diseases. Acute graft-versus-host disease (GvHD) has remained a serious complication of HCT and is associated with high morbidity and mortality especially in patients not responding to first-line therapy with corticosteroids. So far, no standard for salvage therapy of acute corticosteroid-refractory GvHD has been established worldwide. Use of extracorporeal photopheresis results in high response rates, has a steroid-sparing effect and is associated with improved patients’ survival.
Literatur
1.
Zurück zum Zitat Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550–61.PubMedCrossRef Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550–61.PubMedCrossRef
2.
Zurück zum Zitat Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966;62:21–78.PubMed Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966;62:21–78.PubMed
3.
Zurück zum Zitat Paczesny S, Hanauer D, Sun Y, et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant. 2010;45:1–11.PubMedCrossRef Paczesny S, Hanauer D, Sun Y, et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant. 2010;45:1–11.PubMedCrossRef
4.
Zurück zum Zitat Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.PubMedCrossRef Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.PubMedCrossRef
5.
Zurück zum Zitat Flowers MED, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institute of Health consensus criteria. Blood. 2011;117:3214–9.PubMedCrossRef Flowers MED, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institute of Health consensus criteria. Blood. 2011;117:3214–9.PubMedCrossRef
6.
Zurück zum Zitat Jagasia M, Arora M, Flowers MED, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296–307.PubMedCrossRef Jagasia M, Arora M, Flowers MED, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296–307.PubMedCrossRef
7.
Zurück zum Zitat Greinix HT, Loddenkemper C, Pavletic SZ, et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant. 2011;17:167–75.PubMedCrossRef Greinix HT, Loddenkemper C, Pavletic SZ, et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant. 2011;17:167–75.PubMedCrossRef
8.
Zurück zum Zitat Jagasia M, Giglia J, Chinratanalab W, et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health Consensus criteria. Biol Blood Marrow Transplant. 2007;13:1207–15.PubMedCrossRef Jagasia M, Giglia J, Chinratanalab W, et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health Consensus criteria. Biol Blood Marrow Transplant. 2007;13:1207–15.PubMedCrossRef
9.
Zurück zum Zitat Arora M, Nagaraj S, Witte J, et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant. 2009;43:149–53.PubMedCrossRef Arora M, Nagaraj S, Witte J, et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant. 2009;43:149–53.PubMedCrossRef
10.
Zurück zum Zitat Couriel DR, Saliba R, Escalon MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol. 2005;130:409–17.PubMedCrossRef Couriel DR, Saliba R, Escalon MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol. 2005;130:409–17.PubMedCrossRef
11.
Zurück zum Zitat Kuzmina Z, Eder S, Böhm A, et al. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia. 2012;26:746–56.PubMedCrossRef Kuzmina Z, Eder S, Böhm A, et al. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia. 2012;26:746–56.PubMedCrossRef
12.
Zurück zum Zitat Greinix HT. Graft-versus-host disease. Uni-Med Science. 2008. Greinix HT. Graft-versus-host disease. Uni-Med Science. 2008.
13.
Zurück zum Zitat Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295–304.PubMedCrossRef Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295–304.PubMedCrossRef
14.
Zurück zum Zitat Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Brit J Haematol. 1997;97:855–64.CrossRef Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Brit J Haematol. 1997;97:855–64.CrossRef
15.
Zurück zum Zitat Martin PJ, Rizzo JD, Wingard JR, et al. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18:1150–63.PubMedCrossRef Martin PJ, Rizzo JD, Wingard JR, et al. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18:1150–63.PubMedCrossRef
16.
Zurück zum Zitat Van Lint MT, Uderzo C, Locasciulli A, et al. Early treatment of graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood. 1998;92:2288–93.PubMed Van Lint MT, Uderzo C, Locasciulli A, et al. Early treatment of graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood. 1998;92:2288–93.PubMed
17.
Zurück zum Zitat Mielcarek M, Storer BE, Boeckh M, et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood. 2009;113:2888–94.PubMedCrossRef Mielcarek M, Storer BE, Boeckh M, et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood. 2009;113:2888–94.PubMedCrossRef
18.
Zurück zum Zitat MacMillan M, DeFor TE, Weisdorf DJ. The best endpoint for acute GVHD treatment trials. Blood. 2010;115:5412–7.PubMedCrossRef MacMillan M, DeFor TE, Weisdorf DJ. The best endpoint for acute GVHD treatment trials. Blood. 2010;115:5412–7.PubMedCrossRef
19.
Zurück zum Zitat Greinix HT, Knobler R. Extracorporeal photopheresis. De Gruyter. 2013. Greinix HT, Knobler R. Extracorporeal photopheresis. De Gruyter. 2013.
20.
Zurück zum Zitat Greinix HT, Knobler RM, Worel N, et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica. 2006;91:405–8.PubMed Greinix HT, Knobler RM, Worel N, et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica. 2006;91:405–8.PubMed
21.
Zurück zum Zitat Messina C, Locatelli F, Lanino E, et al. Extracorporeal photochemotherapy for pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation. Br J Haematol. 2003;22:118–27.CrossRef Messina C, Locatelli F, Lanino E, et al. Extracorporeal photochemotherapy for pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation. Br J Haematol. 2003;22:118–27.CrossRef
22.
Zurück zum Zitat Greinix HT, Socie G, Bacigalupo A, et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant. 2006;38:265–73PubMedCrossRef Greinix HT, Socie G, Bacigalupo A, et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant. 2006;38:265–73PubMedCrossRef
23.
Zurück zum Zitat Greinix HT, Worel N, Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16:1747–8.PubMedCrossRef Greinix HT, Worel N, Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16:1747–8.PubMedCrossRef
24.
Zurück zum Zitat Perfetti P, Carlier P, Strada P, et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant. 2008;42:609–17.PubMedCrossRef Perfetti P, Carlier P, Strada P, et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant. 2008;42:609–17.PubMedCrossRef
25.
Zurück zum Zitat Calore E, Calo A, Tridello G, et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant. 2008;42:421–5.PubMedCrossRef Calore E, Calo A, Tridello G, et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant. 2008;42:421–5.PubMedCrossRef
26.
Zurück zum Zitat Perotti C, Del Fante C, Tinelli C, et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion. 2010;50:1359–69.PubMedCrossRef Perotti C, Del Fante C, Tinelli C, et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion. 2010;50:1359–69.PubMedCrossRef
27.
Zurück zum Zitat Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graft-versus-host disease. Brit J Haematol. 2012;158:30–45.CrossRef Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graft-versus-host disease. Brit J Haematol. 2012;158:30–45.CrossRef
28.
Zurück zum Zitat Wolff D, Ayuk F, Elmaagacli A, et al. Current practice in diagnosis and treatment of acute graft-versus-host disease—results from a survey among German-Austrian-Swiss HSCT centers. Biol Blood Marrow Transplant. 2013 Jan 29. doi:pil:S1083-8791(13)00054-2. Wolff D, Ayuk F, Elmaagacli A, et al. Current practice in diagnosis and treatment of acute graft-versus-host disease—results from a survey among German-Austrian-Swiss HSCT centers. Biol Blood Marrow Transplant. 2013 Jan 29. doi:pil:S1083-8791(13)00054-2.
Metadaten
Titel
New developments in acute graft-versus-host disease
verfasst von
Hildegard T. Greinix
Margit Mitterbauer, MD
Werner Rabitsch, MD
Nina Worel, MD
Ulrike Just, MD
Robert Knobler, MD
Peter Kalhs, MD
Publikationsdatum
01.06.2013
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2013
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-013-0080-1

Weitere Artikel der Ausgabe 2/2013

memo - Magazine of European Medical Oncology 2/2013 Zur Ausgabe